JEEIX
Price
$19.47
Change
+$0.23 (+1.20%)
Updated
Jun 2 closing price
Net Assets
1.24B
PGJCX
Price
$18.64
Change
+$0.22 (+1.19%)
Updated
Jun 2 closing price
Net Assets
71.56M
Interact to see
Advertisement

JEEIX vs PGJCX

Header iconJEEIX vs PGJCX Comparison
Open Charts JEEIX vs PGJCXBanner chart's image
JEEIX vs PGJCX Comparison Chart in %
View a ticker or compare two or three
VS
JEEIX vs. PGJCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEEIX is a Hold and PGJCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JEEIX has more cash in the bank: 1.24B vs. PGJCX (71.6M). JEEIX pays higher dividends than PGJCX: JEEIX (2.00) vs PGJCX (0.51). JEEIX was incepted earlier than PGJCX: JEEIX (12 years) vs PGJCX (13 years). PGJCX (2.99) is less costly to investors than JEEIX (0.97). PGJCX is a more actively managed with annual turnover of: 78.00 vs. JEEIX (35.00). PGJCX has a lower initial minimum investment than JEEIX: PGJCX (1000) vs JEEIX (250000). JEEIX annual gain was more profitable for investors over the last year : 17.73 vs. PGJCX (6.22). JEEIX return over 5 years is better than : 44.34 vs. PGJCX (19.58).
JEEIXPGJCXJEEIX / PGJCX
Total Expense Ratio0.962.2543%
Annual Report Gross Expense Ratio0.972.9932%
Fund Existence12 years13 years-
Gain YTD8.8986.659134%
Front LoadN/AN/A-
Min. Initial Investment250000100025,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B71.6M1,729%
Annual Yield % from dividends2.000.51395%
Returns for 1 year17.736.22285%
Returns for 3 years62.7931.28201%
Returns for 5 years44.3419.58226%
Returns for 10 years103.1465.25158%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIAHX17.26N/A
N/A
Hartford Healthcare HLS IA
VITNX125.28N/A
N/A
Vanguard Instl Ttl Stk Mkt Idx I
HFMCX21.38N/A
N/A
Hartford MidCap A
GSEUX73.90N/A
N/A
Goldman Sachs US Equity Insights R6
AMFEX21.11N/A
N/A
AAMA Equity